TetraLogic Pharmaceuticals Corporation
TLOG · OTC
9/30/2016 | 6/30/2016 | 3/31/2016 | 12/31/2015 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $38 | $1,499 | $3,302 | $7,149 |
| G&A Expenses | $1,471 | $2,382 | $2,972 | $2,556 |
| SG&A Expenses | $1,471 | $2,382 | $2,972 | $2,556 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $2,251 | $0 | $0 | $0 |
| Operating Expenses | $3,761 | $3,881 | $6,274 | $9,705 |
| Operating Income | -$9,224 | -$5,018 | -$9,341 | -$12,944 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$9,519 | -$2,866 | -$1,725 | -$1,328 |
| Pre-Tax Income | -$10,952 | -$6,747 | -$11,065 | -$14,272 |
| Tax Expense | -$2,317 | $1,718 | $1,679 | $1,642 |
| Net Income | -$8,635 | -$8,464 | -$12,744 | -$15,914 |
| % Margin | – | – | – | – |
| EPS | -0.35 | -0.34 | -0.51 | -0.64 |
| % Growth | -2.9% | 33.3% | 20.3% | – |
| EPS Diluted | -0.35 | -0.34 | -0.51 | -0.64 |
| Weighted Avg Shares Out | 24,769 | 24,769 | 24,769 | 24,781 |
| Weighted Avg Shares Out Dil | 24,769 | 24,769 | 24,769 | 24,813 |
| Supplemental Information | – | – | – | – |
| Interest Income | $8 | $8 | $15 | $17 |
| Interest Expense | $1,759 | $1,718 | $1,679 | $1,642 |
| Depreciation & Amortization | $5,480 | $1,167 | $3,155 | $3,304 |
| EBITDA | -$9,183 | -$5,008 | -$9,313 | -$12,582 |
| % Margin | – | – | – | – |